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Background: Identification of the subset females with Turner syndrome who face especially high risk of aortic
dissection is difficult, and more optimal risk assessment is pivotal in order to improve outcomes. This study aimed
to provide comprehensive, dynamic mathematical models of aortic disease in Turner syndrome by use of
cardiovascular magnetic resonance (CMR).
Methods: A prospective framework of long-term aortic follow-up was used, which comprised diameters of the
thoracic aorta prospectively assessed at nine positions by CMR at the three points in time (baseline [n = 102, age
38 ± 11 years], follow-up [after 2.4 ± 0.4 years, n = 80] and end-of-study [after 4.8 ± 0.5 years, n = 78]). Mathematical
models were created that cohesively integrated all measurements at all positions, from all visits and for all
participants, and using these models cohesive risk factor analyses were conducted based on which predictive
modeling was performed on which predictive modelling was performed.
Results: The cohesive models showed that the variables with effect on aortic diameter were aortic coarctation
(P < 0.0001), bicuspid aortic valves (P < 0.0001), age (P < 0.0001), diastolic blood pressure (P = 0.0008), body surface
area (P = 0.015) and antihypertensive treatment (P = 0.005). Oestrogen replacement therapy had an effect of
borderline significance (P = 0.08). From these data, mathematical models were created that enabled preemption of
aortic dilation from CMR derived aortic diameters in scenarios both with and without known risk factors. The fit of
the models to the actual data was good.
Conclusion: The presented cohesive model for prediction of aortic diameter in Turner syndrome could help
identifying females with rapid growth of aortic diameter, and may enhance clinical decision-making based on
serial CMR.
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A 100-fold increased risk of aortic dissection and rupture
in Turner syndrome (TS) calls for sensitive and specific
risk factors in order to appropriately triage to follow-up
and interventions [1,2]. Aortic dilation is the principal
risk factor for aortic events, [3] which in TS affects
both the ascending and descending thoracic aorta [4].* Correspondence: kristian.havmand@ki.au.dk
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distribution, and reproduction in any mediumHypertension, bicuspid aortic valve, aortic coarctation
and 45,X karyotype are all factors that increase the
likelihood of aortic dilation, accelerated aortic growth
and aortic dilation [5-8]. These risk factors, however,
fail to predict aortic dissection and rupture in a large
proportion of females with TS and current clinical tri-
age must be optimised [4].
The risk of aortic events is presently estimated from
static measurements of aortic diameter, [9] assessing
diameters at individual aortic positions and placing them
into a general comparison with normal calibre at this
position [5-8]. This approach fails to appreciate thetral Ltd. This is an Open Access article distributed under the terms of the
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include the dynamic interrelation between different
measurement positions. There is also a risk of oversim-
plifying risk assessment, since the same aortic diameter
will not confer the same risk in females with or without
risk factors present such as 45,X karyotype, hypertension,
age or enlarged aortic diameter at other positions. In
contemporary best practice only body size is controlled
for [5]. Furthermore, from a mathematical viewpoint
the single-site approach runs the risk of both failing to
acknowledge and overemphasising the relevance of risk
factors. These aspects together with a shortage on longi-
tudinal insight in TS are likely to contribute to our failure
to accurately predict the risk of aortic dissection in this
cohort and enhanced insight is pivotal before outcomes
can be improved [4].
The present study aimed to provide comprehensive
dynamic mathematical models, of cross-sectional and
longitudinal nature, for aortic disease in TS that inte-
grated multiple measuring positions as well as known
risk factors for aortic disease. The aim was to enable
more valid prediction of aortic disease in TS and to opti-




Females with karyotypically proven TS (n = 102) were
recruited through the Danish National Society of Turner
Syndrome Contact Group and a tertiary endocrine out-
patient clinic. Exclusion criteria were malignancy, liver
disease and contraindications to CMR (including mech-
anical aortic valve prostheses). The participants were ex-
amined at baseline, follow-up and end of study using
CMR. As previously described, echocardiography and
24-hour ambulatory blood pressures were also performed
[6,10,11].
Cardiovascular magnetic resonance
CMR was performed with a 1.5 T whole-body scanner
(ACS-NT, Philips Medical Systems; maximum gradient
performance 30 Tesla per meter amplitude, slew rate
150 T/m/sec). A 5-element cardiac coil was used. After
initial scouts, a three-dimensional data stack (27 cm (an-
terior-posterior) × 15 cm × 36 cm (left-right)) covering
the entire thoracic aorta was acquired. A contrast-free,
nearly isotropic, fat-saturated, three-dimensional steady-
state free precession and electrocardiogram-triggered
gradient echo sequence (250 ms diastolic acquisition
window) with a respiratory navigator was used [12]. All
studies were performed by the same staff and in the
same scanner.
Two experienced observers performed a systematic
analysis of the aortic data sets for maximum aorticdiameters with dedicated software (Systematic Software
Engineering, Aarhus, Denmark). The post-processing
methodology allowed reconstruction of the 3D stack of
data in any plane with measurements of aortic diameters
that were truly perpendicular to the aortic wall and the
aortic axis at the measurement position, as described
elsewhere [11]. The observers were blinded to the clin-
ical data of the patient. Aortic or extra-aortic landmarks
guided the measurement positions. The positions were:
(i) aortic sinuses (measuring cusp-to-opposing-cusp
diameter at the point of the maximum aortic diameter
in the aortic sinus); (ii) ascending aorta at the
sinotubular junction; (iii) mid-ascending aorta at the
level of the inferior margin of right pulmonary artery;
(iv) distal ascending aorta immediately proximal to
brachiocephalic artery; (v) proximal aortic arch between
the brachiocephalic and left carotid artery arteries; (vi)
distal aortic arch immediately proximal to left subclavian
artery; (vii) aortic isthmus immediately distal to the left
subclavian artery; (viii) proximal descending aorta be-
tween the left pulmonary artery and the top of left
atrium; and (ix) distal descending aorta at the most cau-
dal border of the left atrium. No systematic bias was
seen on Bland-Altman variability analyses of measure-
ment error, when assessed for inter-observer and intra-
observer variability [11]. Intra-observer variability was
for the above measurement positions: (i) -0.04 (−1.9;1.8)
mm; (ii) 0.02 (−1.8;1.9) mm; (iii) -0.1 (−1.9;1.8) mm;
(iv) -0.1 (−1.9;2.1) mm; (v) 0.20 (−1.6;2.0) mm; (vi) 0.01
(−1.7;1.7) mm; (vii) 0.1 (−1.6;1.4) mm; (viii) 0.08
(−1.5;1.4) mm; and (ix) -0.06 (−1.6;1.7) mm [11]. Inter-
observer variability was: (i) -0.1 (−2.1;2.3) mm; (ii) -0.3
(−2.3;1.8) mm; (iii) -0.1 (−1.9;1.4) mm; (iv) 0.1 (−1.6;1.7)
mm; (v) -0.2 (−1.4;1.9) mm; (vi) -0.01 (−1.6;1.4) mm;
(vii) -0.1 (−1.4;1.9) mm; (viii) 0.08 (−1.1;1.9) mm; and
(ix) 0.1 (−1.2;1.5) mm [11]. Morphological aortic abnor-
malities were detected according to previously described
principles [10].
Ethics
Informed consent was obtained from each participant,
and the study protocol conformed to the ethical guide-
lines of the 1975 Declaration of Helsinki as reflected in a
priori approval by Aarhus County Ethical Scientific
Committee (Denmark) (# 20010248).
Statistical methods
Descriptive statistics
Mathematical computations were performed using SPSS
18.0. Normal distribution of data was tested with
Shapiro-Wilk test, and when not normally distributed
the data was transformed by use of natural logarithmic
conversion. Continuous variables are expressed as
means ± standard deviations with ranges. Data was
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ances by Levene’s test). P < 0.05 was considered
significant.
Mathematical models
The spatial relationship between the nine aorta measure-
ment positions and the temporal dynamics of the three time
points were analysed with a mixed model on the natural
logarithm of aortic diameter. The risk factors in the fixed
part of the model were: age, diastolic blood pressure, aortic
valve morphology, aortic coarctation, antihypertensive medi-
cines and body surface area at each time point. These vari-
ables were entered in the model with position dependent
coefficients. The random parts of the model were composed
of 3 terms: (i) an unstructured covariance matrix describing
the spatial relationship between the positions, (ii) a first
order auto-regression describing the temporal dynamics,
and (iii) position dependent measurement errors, the first
two terms were put together in a so-called Kronecker prod-
uct (see Additional file 1 for further details) [13]. The model
was fitted with SAS/STAT 9.3 PROC MIXED [14]. The
model can be used to make individual baseline predictions
using information on individual risk factors even without
any prior information about previous measured aorta diam-
eter. The model could also be rewritten as a Kalman filter
[15] due to the autoregressive term, in order to forecast aor-
tic diameter from expected developments in the risk factors
and previously obtained aorta measurements. The forecast-
ing model was programmed with the Kalman filter com-
mands in SAS/IML 9.3 [16].
The chosen mathematical model could in a simultan-
eous way handle both the spatial and temporal relation-
ships in the data, and thus took full advantage of the
design with repeated (over time) measurements for mul-
tiple positions. Similar mathematical techniques have been
successfully applied in real time medical imaging, e.g. in
electrocardiography and computerised tomography (please
see Zhang et al. [17] for further references).
The model forecasting aortic diameter is available for




The baseline cohort consisted of 102 females with TS
[6]. Of these, 78 females (age 38 ± 9.9 (19 – 62) years)
with TS (61% 45,X, and 39% other karyotypes) were
followed for 4.8 ± 0.5 (3.5-5.7) years, and they were ex-
amined thrice. The loss to follow-up over the entire
study was due to: (i) exclusion due to chronic Stanford
type A aortic dissection (n = 1), aortic valve surgery
(n = 1) and mitral valve surgery (n = 1); (ii) deaths
(sudden death of unknown cause (n = 2), complications
of elective aortic aneurysm surgery (n = 1), andmetastatic gastric adenocarcinoma (n = 1)), (iii) with-
drawal of consent for non-health related reasons (n =
13), and (iv) technically suboptimal CMR studies
where repeat imaging was declined (n = 4). The co-
horts that participated at each visit (baseline, follow-up
and end of study) are described in Table 1. Data for
baseline and follow-up have been described previously
[6,11].
Aortic diameter
During follow-up aortic diameter increased signifi-
cantly at sinus level, sinotubular junction and mid-
ascending aorta (P < 0.05) (Table 1) with a trend for
growth also in the distal ascending aorta and the pro-
ximal aortic arch (P < 0.07). The remaining aortic posi-
tions were unchanged. Aortic growth rates ranged
from 0.20 ± 0.34 to 0.38 ± 0.46 mm/year for the three
most proximal measurements in the ascending aorta
(Figure 1).
Mathematical modelling
In a mathematical model using all available data points
we first examined whether the different variables had
any effect on aortic diameter at the different positions
along the thoracic aorta. Of these variables (Table 2),
the significant ones were aortic coarctation (P < 0.0001),
bicuspid aortic valves (P < 0.0001), age (P < 0.0001), dia-
stolic blood pressure (P = 0.0008), body surface area
(P = 0.015), and antihypertensive treatment (P = 0.005).
Duration of oestrogen replacement therapy had an effect
of borderline significance (P = 0.08). In this combined
model karyotype 45,X (compared to any other karyo-
type), aortic valve function and elongated transverse aor-
tic arch did not contribute. The modelling thus showed
that aortic coarctation, bicuspid aortic valve, age, dia-
stolic blood pressure, body surface area and antihyper-
tensive medicines all influenced aortic diameter at least
at one position. We subsequently studied the percentage
change in aortic diameter that a given change in some of
the studied variables led to, in order to gauge the effect
sizes of these variables (Table 3). For example it could
be appreciated that the presence of BAV increases the
aortic diameter at the point of the aortic sinus with
10.39%, while receiving antihypertensive treatment re-
duces the diameter by 4.02% at the same measuring
point.
We then proceeded to assess how these influencing
variables determined aortic diameter by posing the
question: is the nature of this influence uniform or does
it vary from position to position through the thoracic
aorta? These analyses showed that aortic diameter (at
other positions), aortic coarctation, bicuspid aortic valve,
age, and diastolic blood pressure had a position-dependent
effect on aortic diameter, whereas body surface area
Table 1 Females with Turner syndrome followed with three visits over 4.8 years using CMR
Baseline Follow up End of study
Participants (n) 102 89 82
Total exit from study (n) - 13 20
Technically successful study (n) 102 (100%) 80 (90%) 78 (95%)
Age (years) 38 ± 11 41 ± 11 43.0 ± 10
Follow up time (years) - 2.4 ± 0.4 4.8 ± 0.5
Body surface area (m2) 1.5 ± 0.2 1.5 ± 0.2 1.5 ± 0.1
Karyotype (45,X/other) 58%/42% 60%/40% 61%/39%
Oestrogen replacement therapy 86% 85% 82%
Antihypertensive treatment 29% 28% 55%
Statin treatment 6% 9% 13%
Diabetes 5% 8% 12%
Previous growth hormone treatment 27% 26% 22%
Ambulatory blood pressure
24-hour systolic (mm Hg) 122 ± 14 122 ± 14 117 ± 13
24-hour diastolic (mm Hg) 77 ± 11 78 ± 11 75 ± 8
24-hour heart rate (beats/min) 76 ± 10 77 ± 9 74 ± 9
Aortic dimensions (mm)
Aortic sinus 29.1 ± 4.0 29.2 ± 3.0 * 31.0 ± 4.4 *
Sinotubular junction 25.4 ± 4.7 25.3 ± 4.3 26.3 ± 4.6 *
Mid-ascending aorta 27.4 ± 6.7 27.5 ± 5.0 28.6 ± 5.2 *
Distal ascending aorta 25.4 ± 4.0 25.5 ± 3.6 25.8 ± 3.7
Proximal aortic arch 23.5 ± 3.7 23.4 ± 3.6 23.9 ± 3.5
Mid aortic arch 20.5 ± 2.6 20.5 ± 2.7 20.7 ± 2.6
Distal transverse aortic arch 19.3 ± 2.4 19.3 ± 2.3 19.4 ± 2.3
Proximal descending 19.4 ± 2.9 19.5 ± 2.8 19.8 ± 3.4
Distal descending aorta 18.2 ± 2.4 18.2 ± 2.2 18.3 ± 2.5
Aortic valve and aortic anomalies
Bicuspid aortic valve 25% 28% 30%
Aortic stenosis † 12% (7%/4%/1%) 11% (8%/3%/-) 13% (9%/4%/-)
Aortic regurgitation † 22% (16%/5%/1%) 21% (18%/3%/-) 23% (17%/5%/1%)
Elongated transverse aortic arch 47% 48% 48%
Aortic coarctation ‡ 12% 11% 10%
Continuous variable are expressed as means ± standard deviations.
* P < 0.05 using Student’s paired t-test to compare baseline and end of study.
† Percentages describe grades of dysfunction (mild/moderate/severe). There was no significant change in valvar indices during the follow-up.
‡Morphological aortic coarcation on CMR.
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aorta (Table 4). The aforementioned parameters had a
stronger influence on the proximal ascending aorta than
on the descending thoracic aorta. Even though the size
of the interaction was position specific as described, the
presence of bicuspid valves, aortic coarctation, raised
blood pressure (and antihypertensive treatment), ad-
vanced age, and increased body surface area were all
associated with increased aortic diameters (except
around the classical site of aortic coarctation inindividuals with such arch morphology). We also stu-
died the effect of oestrogen replacement closer and this
analysis showed that this treatment had a 'negative' ef-
fect on aortic diameter in the ascending aorta (position
1 and 2 – associated with a smaller aortic diameter),
while it had a marginally positive influence on diameter
in the remaining thoracic aorta.
Model checking included a normal probability plot of
the standardised residuals and a scatter plot of the resi-
duals against fitted values (Additional file 1: Figures S1
Figure 1 Aortic growth rates (mean and 95% confidence intervals) during 4.8 ± 0.5 years of CMR in Turner syndrome (n = 78). * P < 0.05
when comparing baseline to follow-up using Students independent t-test.
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basic assumptions. The plots were further subdivided
with respect to time (3 groups) and to aortic position
(9 groups), and these plots (not shown) confirmed the
impression that the model fitted the data well.
Modelling aortic diameter and growth
We designed a forecasting model, allowing prediction of
changes in aortic diameter over time. This model was
flexible, and allowed use in two versions. In one version,
modelling can be performed without knowledge of prior
aortic imaging and on the basis of other accessible data
such as body surface area, blood pressure, and aortic
valve status. In another version, baseline or even follow-
up measurements of the aorta may be entered in
addition to other risk factors. Not surprisingly, the ac-
curacy of the modelling improved with the use of mul-
tiple aortic measurements. The prediction model also
highlighted that it is possible to categorise females with
TS into low and high risk for more or less rapid aortic
dilation based on a number of risk parameters present,
such as previous measurement of the aorta. In Figure 2A,
2C and 2E we present data from three females at diffe-
rent ends of the risk spectrum, running their data
through the model. The figures demonstrate that risk
factors additively predict progressive aortic dilation over
time, especially in the ascending aorta, and that aorticgrowth primarily takes place in the ascending aorta closest
to the aortic valves. Some females displayed growth
according to prediction while others demonstrated rapid
growth of the aorta exceeding the boundaries of the pre-
diction limits of the model (Figure 2B, 2D and 2F), and
we speculate that such individuals should be considered
for more targeted medical or surgical intervention [9].
Discussion
The entire thoracic aorta is at risk of dilation and dissec-
tion in TS [7,11]. The present study utilised a dynamic
and integrative approach to both baseline CMR data and
to the longest registered prospective characterisation of
aortic diameter of the entire thoracic aorta in TS. The
presented model provides a cohesive analysis of aortic
disease by incorporating all parameters that have been
identified to impact the thoracic aorta in TS with the
goal to more completely estimate of the total risk bur-
den. The mathematical modelling included every mea-
surement performed in each individual at all study visits,
creating a correlation matrix of more than 2,000 sepa-
rately assessed aortic diameters.
Growth of the thoracic aorta was dynamic over time,
and the presently acknowledged risk factors impacted
diameters in different ways at different positions within
the thoracic aorta. Risk factors such as age, bicuspid aor-
tic valves, blood pressure, antihypertensive treatment,
Table 2 Initial modeling with relevant parameters thought to influence aortic diameter in Turner syndrome in a cohesive mathematical model
Variable CoA Age BAV Antihypertensive
treatment
Diastolic ABP BSA ERT duration Karyotype ETA
Position
Aortic sinus 0.04 0.0030 0.100 −0.041 −0.0006 0.17 0.0020 −0.06 0.0357
(−0.04 - 0.12) (0.0005 – 0.0056) (0.038 – 0.160) (−0.067 - -0.015) (−0.0017 – 0.0005) (−0.01 – 0.35) (−0.0007 – 0.0046) (−0.12 - -0.01) (−0.0208 – 0.0923)
Sinotubular junction −0.02 0.0031 0.129 −0.007 −0.0005 0.06 0.0017 −0.08 0.0165
(−0.11 – 0.08) (0.0003 – 0.0059) (0.055 – 0.203) (−0.034 – 0.018) (−0.0017 – 0.0006) (−0.14 – 0.25) (−0.0013 – 0.0047) (−0.14 - -0.01) (−0.0515 – 0.0846)
Mid-ascending aorta −0.06 0.0060 0.174 −0.010 0.0008 0.05 −0.0003 −0.06 0.0115
(−0.16 – 0.04) (0.0032 – 0.0089) (0.097 – 0.252) (−0.034 – 0.014) (−0.0003 – 0.0018) (−0.14 – 0.24) (−0.0034 – 0.0027) (−0.13 – 0.01) (−0.0598 – 0.0828)
Distal ascending aorta −0.03 0.0045 0.078 0.003 0.0008 0.10 −0.0022 −0.03 −0.00001
(−0.11 – 0.05) (0.0021 – 0.0068) (0.015 – 0.141) (−0.018 – 0.024) (−0.0001 – 0.0017) (−0.06 – 0.26) (−0.0048 – 0.0003) (−0.09 – 0.02) (−0.0580 – 0.0579)
Proximal aortic arch −0.07 0.0034 0.081 −0.012 0.0001 0.17 −0.0032 −0.05 −0.0108
(−0.16 – 0.02) (0.0009 – 0.0059) (0.016 – 0.145) (−0.037 – 0.014) (−0.0011 – 0.0013) (−0.001 – 0.35) (−0.0058 – 0.0005) (−0.11 – 0.01) (−0.0702 – 0.0487)
Mid aortic arch −0.06 0.0009 0.008 −0.008 0.0009 0.16 −0.0009 −0.02 −0.0456
(−0.14 – 0.02) (−0.0013 – 0.0032) (−0.051 – 0.067) (−0.029 – 0.013) (−0.0001 – 0.0018) (−0.002 – 0.31) (−0.0033 – 0.0015) (−0.07 – 0.04) (−0.1000 – 0.0088)
Distal transverse aortic arch −0.02 0.0026 0.024 0.006 0.0016 0.19 −0.0006 −0.03 −0.0241
(−0.08 – 0.05) (0.0006 – 0.0046) (−0.025 – 0.073) (−0.016 – 0.027) (0.0007 – 0.0025) (0.04 – 0.33) (−0.0027 – 0.0016) (−0.08 – 0.01) (−0.0692 – 0.0210)
Proximal descending 0.21 0.0007 0.051 −0.014 0.0009 0.12 0.0001 −0.04 0.0037
(0.13 – 0.29) (−0.0016 – 0.0030) (−0.009 – 0.110) (−0.034 – 0.006) (−0.0001 – 0.0017) (−0.04 – 0.27) (−0.0024 – 0.0025) (−0.10 – 0.01) (−0.0508 – 0.0583)
Distal descending aorta 0.14 0.0034 0.047 0.010 0.0014 0.20 −0.0008 −0.04 −0.0163
(0.07 – 0.20) (0.0016 – 0.0052) (−0.0005 – 0.0094) (−0.008 – 0.028) (0.0006 – 0.0021) (0.07 – 0.32) (−0.0027 – 0.0012) (−0.08 – 0.005) (−0.0597 – 0.0270)
P value <0.0001 <0.0001 0.0004 0.005 0.0008 0.02 0.08 0.2 0.4
The β estimates (95% confidence interval) are presented for each aortic position, and at the bottom of the table the p-value indicates whether the parameter influences the thoracic aorta at any point.

















Table 3 Percentage change in aortic diameter due to one unit increase in the variables influencing aortic diameter
(based on the findings in Table 2)








Aortic sinus 4.42 0.30 10.39 −4.02 −0.62 1.62 0.20 3.64
Sinotubular junction −1,54 0.31 13.76 −0.74 −0.53 0.54 0.17 1.67
Mid-ascending aorta −5.81 0.60 19.03 −0.99 0.78 0.52 −0.03 1.15
Distal ascending aorta −3.10 0.45 8.12 0.31 0.84 0.96 −0.22 0.00
Proximal aortic arch −6.73 0.34 8.39 −1.15 0.10 1.68 −0.31 −1.07
Mid aortic arch −5.66 0.09 0.80 −0.77 0.86 1.49 −0.09 −4.45
Distal transverse aortic arch −1.70 0.26 2.41 0.55 1.64 1.81 −0.06 −2.39
Proximal descending 23.40 0.07 5.19 −1.39 0.86 1.14 0.01 0.37
Distal descending aorta 14.43 0.34 4.77 1.00 1,37 1.94 −0.08 −1.62
P value <0.0001 <0.0001 0.0004 0.005 0.0008 0.02 0.08 0.4
For BITRI, ETA and antihypertensive treatment we present the percentage change in diameter in the presence of these variables (in contrast to the normal
condition of a tricuspid valve, no ETA and no antihypertensive treatment). For ERT duration we examined the additive effect of one additional year of treatment.
For diastolic blood pressure we examined the percentage change in the aortic diameter due to a 10 mmHg increase and for BSA due to 10% increase. The
p-value indicates whether the parameter influences the thoracic aorta at any point.
Abbreviations: COARC aortic coarctation, BITRI the presence of a bicuspid aortic valve, ABP ambulatory blood pressure, BSA Body surface area, ERT oestrogen
replacement, ETA elongated transverse aortic arch.
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of the ascending aorta. Higher body surface area associ-
ated with larger aortic diameters, but in contrast to the
former variables the interaction of body surface area was
uniform across the thoracic aorta. Our findings empha-
sise that even though some risk factors may be congeni-
tal, there is a window of opportunity to prevent (or at
least reduce) the age-related progressive aortic dilatation.
Notably, hypertension is extremely frequent in TS,
[18-20] and medical intervention may both reduce hyper-
tensive wall shear stress and directly inhibit aortic wall
disease [21,22] though drug trials are lacking in
TS [1]. Hypertension was highly prevalent, markedly
underdiagnosed and undertreated at baseline. Aortic
diameter was higher in females who were being treated
for hypertension, which is not due to a negative influence
of antihypertensive drugs but rather the result of their
underlying hypertensive disease. Hypertension is not the
only modifiable risk factor. Careful handling of obesity
and metabolic diseases that are common in TS may also
improve aortic outcomes since aortic diameters are
closely linked with body surface area [23]. As for the con-
genital risk factors, aortic valve morphology and aortic
coarctation were both significant contributors whereas
karyotype did not explain the variation in aortic diameter
in our models. Previously, the 45,X karyotype has been
established to associate with unfavourable aortic pheno-
types in TS [10,24]. The lack of an association in our ana-
lyses is likely due to karyotype having an indirect
influence via the associated traits such as bicuspid aortic
valves and aortic coarctation.
Aortic growth rate is used as an additional risk factor
for aortic dissection [9]. Here, the longest aortic follow-up in TS confirms the findings of previous studies
[11,25], underpinning the aggressive nature of aortic dis-
ease in TS with growth rates that here ranged from 0.20
to 0.38 mm/year (and even higher rates were seen in a
few patients in the ascending aorta). These growth rates
are well beyond the general population and compares to
other cohorts with aortic disease [26,27].
Our models infer that although the association be-
tween growth rates and age may seem linear, the nature
of this relation is highly dependent on the position in
the thoracic aorta. In clinical terms this means that ac-
celerated growth may be present at certain positions
along the aorta, whereas other positions undergo less
pronounced change (and this picture may change over
time and with interventions). The present model also
highlights that a factor such as age is a principal player
in the progression towards aortic dilation. Aortic dissec-
tion occurs four decades prematurely in TS and our
findings reiterate that triaging for follow-up also should
include the patients’ age [28].
The pervasive mapping of aortic phenotype with CMR
over multiple visits enabled us to provide the first inte-
grative model of the thoracic aorta in TS (Figure 2). Our
models provide a ‘risk engine’ that predicts aortic dia-
meter of a female with TS based on her actual risk fac-
tors. This may prove a valuable tool in the clinical
assessment of aortic disease, when a female with TS is
seen for the first time or when new risk factors are diag-
nosed in clinic as can be expected from the natural course
of the syndrome [29]. By use of the model the clinician
can compare any measured aortic size of a particular pa-
tient to the models reference values, and hereby get an
understanding of the degree of enlargement of the aorta
Table 4 Integrating all nine aortic positions mapped by CMR in the forecasting model, producing interaction terms to describe the nature of the influence
Variable COARC Age BITRI Antihypertensive treatment Diastolic ABP BSA ERT duration
Aortic sinus 0.06 0.002 0.11 −0.041 −0.0006 0.20 0.0025
(−0.02 - 0.14) (−0.0002 – 0005) (0.05 – 0.17) (−0.067 - -0.015) (−0.0017 – 0.0005) (0.02 – 0.38) (−0.0002 - 0.0052)
Sinotubular junction −0.002 0.003 0.14 −0.007 −0.0005 0.09 0.0023
(−0.01 – 0.10) (−0.0002 – 0.005) (0.07 – 0.21) (−0.032 – 0.019) (−0.0016 – 0.0006) (−0.11 – 0.28) (−0.0007 - 0.0053)
Mid-ascending aorta −0.05 0.006 0.18 −0.010 0.0008 0.07 0.00005
(−0.15 – 0.05) (0.0003 – 0.008) (0.11 – 0.26) (−0.034 – 0.014) (−0.0002 – 0.0018) (−0.12 – 0.26) (−0.0030 - 0.0031)
Distal ascending aorta −0.03 0.004 0.08 0.003 0.0009 0.11 −0.0021
(−0.11 – 0.05) (0.002 – 0.007) (0.02 – 0.14) (−0.018 – 0.023) (0.00005 – 0.0017) (−0.05 – 0.27) (−0.0045 - 0.0004)
Proximal aortic arch −0.07 0.003 0.08 −0.011 0.0001 0.19 −0.0028
(−0.15 – 0.02) (0.0007 – 0.006) (0.02 – 0.14) (−0.036 – 0.015) (0.0010 – 0.0013) (0.01 – 0.36) (−0.0055 - -0.0002)
Mid aortic arch −0.07 0.001 −0.003 −0.007 0.0009 0.15 −0.0010
(−0.15 -0.01) (−0.001 – 0.003) (−0.06 – 0.05) (−0.029 – 0.014) (0.00004 – 0.0018) (−0.01 – 0.30) (−0.0034 - 0.0014)
Distal transverse aortic arch −0.02 0.003 0.02 0.006 0.0017 0.20 −0.0003
(−0.08 – 0.05) (0.0006 – 0.004) (−0.03 – 0.07) (−0.015 – 0.028) (0.0007 – 0.0026) (0.06 – 0.34) (−0.0024 - 0.0018)
Proximal descending 0.22 0.0004 0.05 −0.014 0.0009 0.13 0.0004
(0.14 – 0.29) (−0.002 – 0.003) (−0.003 – 0.11) (−0.034 – 0.006) (−0.00002 – 0.0017) (−0.02 – 0.29) (−0.0020 - 0.0028)
Distal descending aorta 0.14 0.003 0.04 0.011 0.0014 0.21 −0.0005
(0.08 – 0.20) (0.002 – 0.005) (−0.002 – 0.09) (−0.007 – 0.029) (0.0006 – 0.0022) (0.08 – 0.34) (−0.0025 - 0.0014)
P value <0.0001 <0.0001 0.0004 0.002 0.01 0.6 0.06
Here, we present the interaction terms for parameters that showed an effect on the development in aortic diameter. The β estimates (95% confidence interval) are presented for all aortic positions, and at the bottom
of the table p-values are presented. In cases where an interaction term shows an insignificant p-value this indicates that the parameter had a uniform effect on the development of the thoracic aortic diameter. A
significant p-value indicates that a parameter influences the development of the thoracic aortic diameter in a variable fashion over time. For example, the presence of a bicuspid aortic valve influenced the entire
thoracic aorta, but the effect was most pronounced in the ascending aorta.

















Figure 2 Mathematical modelling of aortic diameter in Turner syndrome with varying burdens of risk factors for aortic complications,
aiming to validate the predictive models against actual data collected in three real patients. Aortic measurement position (nine: from
aortic sinuses to descending thoracic aorta) is depicted on the x-axis. A) Perceived low risk burden: 26-year old, tricuspid aortic valve, no aortic
coarctation, ambulatory blood pressure (ABP) 104/66 mmHg, body surface area (BSA) 1.46 m2, and karyotype 45,X (dots: actual measurement at
baseline; full black line: prediction at baseline from modelling of the complete cohort (n = 102); dotted lines: 95% prediction limits). B) Same low-
risk female (as in A) (dots: actual measurement at 4 years; full black line: 4 year prediction; dotted lines: 95% prediction limits; full red line: prediction
at 8 years from baseline). C) Perceived high risk burden: 49-year old, bicuspid valves, aortic coarctation, hypertension (ABP 124/67 mmHg during
antihypertensive treatment), BSA 1.60 m2, and karyotype 45,X/46,X,r(X) (dotted line: actual measurement at baseline; full line: prediction at baseline;
dotted lines: 95% prediction limits). D) Same high-risk female (as in 2C) (dots: actual measurement at 4 years; full black line: 4 year prediction;
dotted lines: 95% prediction limits; full red line: prediction at 8 years from baseline). E) Perceived high risk burden: 43-year old, bicuspid valves, no
aortic coarctation, diagnosed hypertension (ABP 143/90 mmHg during antihypertensive treatment), BSA 1.47 m2, and karyotype 45,X (dotted line:
actual measurement at baseline; full line: prediction at baseline; dotted lines: 95% prediction limits). F) Same high-risk female (as in E) (dots: actual
measurements at 4 years; full black line: 4 year prediction; dotted lines: 95% prediction limits; full red line: 8 yeard prediction), and please note that
ascending aortic measurements fell outside the prediction. Please also see www.biostat.au.dk/MERL/Aorta_Prediction_model.htm.
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to ascertain a predicted impact of an occurrence such as
onset of hypertension, which may aid in scheduling the
most appropriate and timely follow-up or possibly guide
interventions. Our models clearly show that the impact of
different risk factors is far from trivial, and that all should
be included in the planning of surveillance of the thoracic
aorta in TS. Important for the external validity of this pre-
dictive model, the registration of aortic diameter was not
only performed by gold standard imaging [3,9] but also
carried out in a clinically applicable setting where risk
modifications were adapted as cardiovascular risk factors
emerged. This is in contrast to a controlled clinical setting
that would not translate into a model of daily clinical
practice.
It would have been optimal to link this model with
aortic dissection and rupture, but no definitive aortic
event occurred in this cohort despite several participants
being excluded from follow-up due to cardiothoracic
surgery and death of unknown cause. There is a lack of
evidence-based guidelines for planning of monitoringand interventions for the dilated aorta in TS [3,9,30].
A critical cut-off level for aortic diameter remains to be
defined. In light of the shortage of evidence, we had to
take a pragmatic approach in two females with gross dila-
tion of their ascending aorta. At baseline, a 24-year old
female with a mid-ascending aortic diameter of 48 mm
and bicuspid aortic valve had aortic surgery. Unfortu-
nately, she died immediately after surgery due to compli-
cations relating to an aberrant origin of her left anterior
descending coronary artery (origin from the distal as-
cending aorta). At the end of the study, a 43-year old fe-
male (Figure 2E), who presented with a bicuspid aortic
valve and progressed in her aortic sinus diameter from
40 to 52 mm over 5 years, had the same surgical proced-
ure performed with a good result. These cases illustrate
the paradigm associated with gathering outcome-based
evidence for aortic diameter and dissection in TS, as it
is ethically difficult to carry out truly observational stu-
dies without intervening. It also needs to be remembered
that even though the risk of aortic dissection may be
100-fold increased, this event is not a common clinical
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http://jcmr-online.com/content/15/1/47occurrence, since it will only affect 1-2% of TS over their
entire lifetime. We will continue to explore outcomes in
this cohort, and hopefully provide more insight into the
relation between aortic diameter and aortic events in TS.
Future perspectives
Our models are the first of their kind for disease in the
thoracic aorta. They lend promise of becoming a valu-
able clinical tool that should optimally be validated in
other large cohorts of TS (including children and adoles-
cents). Further modelling might even include similar
‘risk engines’ that predict aortic diameter using CMR on
a population level, where TS might be one of many risk
factors entered into the models alongside age, bicuspid
aortic valve, aortic coarctation, body surface area,
Marfan syndrome or other thoracic aortic dilation syn-
dromes. Improving outcomes in aortic disease is pivotal,
and our work adds to other important areas of focus in the
improvement of prognosis in aortic disease [9]. Linearity
has hither to been assumed when it comes to modelling
aortic growth and when using serial studies for risk assess-
ment, [11,26,27] but according to our data this may be a
somewhat crude assumption. This complicates assess-
ment of change between any two studies (and the clin-
ical implications hereof) because a change may vary
highly with time in a non-linear fashion. There is, as
proposed here, a need for inclusion of more factors than
time and diameter, and it will in the future be essential to
clarify how different parts of the aorta grow differentially
over different time periods and in the presence of different
combinations of risk factors.
Study limitations
The model treated all participants lost to follow-up
(n = 20) as non-informative (or ‘missing at random’ in
the mathematical terminology). Of these, some females
(n = 13) were lost for non-health related reasons and no
events occurred here; the assumption that this loss to
follow-up is non-informative seems reasonable. For the
remaining participants (n = 7) that were lost to follow-up,
they either were or could have been lost for reasons as-
sociated with aortic diameter. Hence, the assumption
that they were ‘missing at random’ may be violated. Such
an association could also create a selection problem in
the data similar to the healthy worker effect and hence
introduce bias in the estimates. However, the number
of exits is too small for a more extensive mathematical
evaluation.
Some limitations in the autoregressive temporal relation-
ship are imposed by existing software (SAS PROC MIXED)
and improvements could be obtained by addressing two as-
pects: (i) multivariate (spatial) data can only be fitted as an
auto-regression with constant time interval between the
observations, approximately 2 years for this study,and hence the Kalman filter based on our estimates
can only be applied in similar situations; and (ii) the
autoregressive model with only a single parameter
common for all aorta positions is very intuitive but
could be too simplistic. Such improvements would,
however, require much more specialised software.
Conclusion
The robust mathematical model shows the importance
of several risk factors for dilation of the thoracic aorta in
TS. This cohesive model for prediction of aortic dia-
meter, which included all aortic measurements for se-
veral time points at the same time, could serve to identify
patients with rapid growth of aortic diameter, to aid
clinical decision-making based on CMR studies, and may
also prove useful in future imaging studies.
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